DFDA

Clinical Trials for Type 2 Diabetes

Focusing on: DPP-4 Inhibitors

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 243 results.

Page 1 of 25
A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients
Completed
Conditions:Type 2 Diabetes
Study Type: INTERVENTIONAL
Phase: PHASE2
Enrollment: 64
Age: 18 Years - 75 Years
Gender: ALL
Locations: Chu Hsien-I Memorial Hospital, Tianjin Medical University
View Study Details
Use of Incretins in Diabetic Patients
Completed
Interventions:DPP-4 inhibitors
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 2234
Age: From 18 Years
Gender: ALL
Locations: IRCCS Policlinico San Matteo Foundation
View Study Details
Study of Sulphonylurea Synergy With DPP4 Inhibitors
Completed
Conditions:Type 2 Diabetes
Study Type: INTERVENTIONAL
Phase: NA
Enrollment: 30
Age: 40 Years - 80 Years
Gender: ALL
Locations: Ninewells Hospital and Medical School
View Study Details
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
Active, Not Recruiting
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 200000
Age: From 19 Years
Gender: ALL
Locations: Yongin Severance Hospital, Yonsei University Health System
View Study Details
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Terminated
Study Type: INTERVENTIONAL
Phase: NA
Enrollment: 5
Age: 18 Years - 75 Years
Gender: ALL
Locations: Gastroenterology Department Erasme Hospital
View Study Details
Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors
Completed
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 333580
Age: From 18 Years
Gender: ALL
Locations: RTI health solutions
Has Results
View Study Details
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
Completed
Study Type: INTERVENTIONAL
Phase: PHASE3
Enrollment: 106
Age: From 20 Years
Gender: ALL
Locations: N/A
View Study Details
Empa PASS on Urinary Tract Malignancies
Completed
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 344995
Age: From 18 Years
Gender: ALL
Locations: The National Register Data; The Swedish prescribed drug register; +1 more
Has Results
View Study Details
The Effect of DPP4 Inhibitor on Vasclular Healing
UnknownLast Known: RECRUITING
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 66
Age: From 20 Years
Gender: ALL
Locations: Keimyung University Hospital; Chonnam National University Hospital; +4 more
Join Study
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
UnknownLast Known: RECRUITING
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 550000
Age: From 30 Years
Gender: ALL
Locations: HealthCore, Inc.; Humana; +3 more
Join Study